Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $381,018 - $441,934
4,116 New
4,116 $438,000
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $31,611 - $36,659
395 Added 7.44%
5,705 $525,000
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $1,662 - $2,035
-22 Reduced 0.41%
5,310 $482,000
Q2 2022

Aug 16, 2022

SELL
$80.52 - $93.75 $38,166 - $44,437
-474 Reduced 8.16%
5,332 $451,000
Q1 2022

May 24, 2022

BUY
$80.11 - $90.62 $465,118 - $526,139
5,806 New
5,806 $509,000
Q2 2021

Aug 19, 2021

SELL
$85.24 - $94.15 $491,579 - $542,963
-5,767 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$83.5 - $98.47 $481,544 - $567,876
5,767 New
5,767 $493,000
Q2 2019

Aug 16, 2019

SELL
$75.4 - $92.8 $222,957 - $274,409
-2,957 Closed
0 $0
Q1 2019

May 17, 2019

BUY
$75.32 - $86.15 $222,721 - $254,745
2,957 New
2,957 $284,000
Q4 2018

Feb 15, 2019

SELL
$73.66 - $82.02 $240,499 - $267,795
-3,265 Closed
0 $0
Q3 2018

Nov 16, 2018

SELL
$66.94 - $77.43 $407,062 - $470,851
-6,081 Reduced 65.07%
3,265 $281,000
Q2 2018

Aug 17, 2018

BUY
$64.91 - $73.36 $606,648 - $685,622
9,346 New
9,346 $706,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.